GoodRx to Participate in Upcoming Investor Conferences
GoodRx Holdings (Nasdaq: GDRX), the leading prescription savings platform in the U.S., has announced its participation in two major healthcare investor conferences. The company will engage in fireside chats at the UBS 2024 Global Healthcare Conference in Rancho Palos Verdes on November 12, 2024, and the Citi 2024 Global Healthcare Conference in Miami on December 5, 2024.
Live webcasts of both events will be accessible through GoodRx's Investor Relations website, with recordings remaining available for at least 30 days after each conference.
GoodRx Holdings (Nasdaq: GDRX), la principale piattaforma di risparmio sui farmaci negli Stati Uniti, ha annunciato la sua partecipazione a due importanti conferenze per investitori nel settore sanitario. L'azienda parteciperà a conversazioni informali durante il UBS 2024 Global Healthcare Conference a Rancho Palos Verdes il 12 novembre 2024 e al Citi 2024 Global Healthcare Conference a Miami il 5 dicembre 2024.
I webcast in diretta di entrambi gli eventi saranno accessibili tramite il sito web delle Relazioni con gli Investitori di GoodRx, con registrazioni disponibili per almeno 30 giorni dopo ciascuna conferenza.
GoodRx Holdings (Nasdaq: GDRX), la principal plataforma de ahorro en recetas en EE. UU., ha anunciado su participación en dos importantes conferencias de inversionistas en el sector salud. La empresa participará en charlas informales en la Conferencia Global de Salud UBS 2024 en Rancho Palos Verdes el 12 de noviembre de 2024 y en la Conferencia Global de Salud Citi 2024 en Miami el 5 de diciembre de 2024.
Las transmisiones en vivo de ambos eventos estarán disponibles a través del sitio web de Relaciones con Inversores de GoodRx, con grabaciones que permanecerán accesibles durante al menos 30 días después de cada conferencia.
GoodRx Holdings (Nasdaq: GDRX), 미국에서 가장 큰 처방전 절약 플랫폼은 두 개의 주요 의료 투자자 konferanss에 참여할 것이라고 발표했습니다. 회사는 2024년 11월 12일 론초 팔로스 베르데스에서 개최되는 UBS 2024 글로벌 헬스케어 컨퍼런스와 2024년 12월 5일 마이애미에서 열리는 Citi 2024 글로벌 헬스케어 컨퍼런스에서 비공식 대화에 참여합니다.
두 이벤트의 실시간 웹 캐스트는 GoodRx의 투자자 관계 웹사이트를 통해 접근할 수 있으며, 각 회의 후 최소 30일 동안 녹음본이 제공됩니다.
GoodRx Holdings (Nasdaq: GDRX), la principale plateforme d'économies sur les prescriptions aux États-Unis, a annoncé sa participation à deux grandes conférences d'investisseurs dans le domaine de la santé. L'entreprise participera à des discussions informelles lors de la Conférence Mondiale de la Santé UBS 2024 à Rancho Palos Verdes le 12 novembre 2024, et à la Conférence Mondiale de la Santé Citi 2024 à Miami le 5 décembre 2024.
Les webinaires en direct des deux événements seront accessibles via le site des Relations Investisseurs de GoodRx, avec des enregistrements disponibles pendant au moins 30 jours après chaque conférence.
GoodRx Holdings (Nasdaq: GDRX), die führende Plattform zur Einsparung von Rezeptkosten in den USA, hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im Gesundheitswesen angekündigt. Das Unternehmen wird an informellen Gesprächen auf der UBS 2024 Global Healthcare Conference in Rancho Palos Verdes am 12. November 2024 und der Citi 2024 Global Healthcare Conference in Miami am 5. Dezember 2024 teilnehmen.
Live-Streams beider Veranstaltungen werden über die Investor Relations-Website von GoodRx zugänglich sein, und Aufzeichnungen werden mindestens 30 Tage nach jeder Konferenz verfügbar bleiben.
- None.
- None.
-
UBS 2024 Global Healthcare Conference in
Rancho Palos Verdes, CA , on Tuesday, November 12, 2024 at 2 p.m. Eastern Time (11 a.m. Pacific Time) -
Citi 2024 Global Healthcare Conference in
Miami, FL , on Thursday, December 5, 2024 at 8:45 a.m. Eastern Time (5:45 a.m. Pacific Time)
A live webcast of each of the foregoing events will be available on the Company's Investor Relations website, https://investors.goodrx.com/. Following each conference, an archived recording will be available on the Company’s website for at least 30 days.
About GoodRx
GoodRx is the leading prescription savings platform in the
GoodRx periodically posts information that may be important to investors on its investor relations website at https://investors.goodrx.com. We intend to use our website as a means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors and potential investors are encouraged to consult GoodRx’s website regularly for important information, in addition to following GoodRx’s press releases, filings with the Securities and Exchange Commission and public conference calls and webcasts. The information contained on, or that may be accessed through, GoodRx’s website is not incorporated by reference into, and is not a part of, this press release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241104739401/en/
Investor Contact
GoodRx
Aubrey Reynolds
ir@goodrx.com
Press Contact
GoodRx
Lauren Casparis
lcasparis@goodrx.com
Source: GoodRx Holdings, Inc.
FAQ
When is GoodRx (GDRX) presenting at the UBS Healthcare Conference 2024?
What time is GoodRx's (GDRX) presentation at the Citi Healthcare Conference 2024?
How can I watch GoodRx's (GDRX) investor conference presentations?